Trends in Influenza Vaccination Among Pregnant Women: A Secondary Analysis of PRAMS
Abstract
The CDC Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists recommend that all pregnant women receive the annual influenza vaccine to protect themselves and their infants. Because flu vaccines cannot be given to infants less than six months of age, vaccinating pregnant mothers allows influenza antibodies to pass on to the infant and protect them for the first months of life. Despite these longstanding public health recommendations, recent data collected by the CDC found that influenza vaccination rates among pregnant women were under 50% in the 2023-2024 flu season. To examine broader trends over time in influenza vaccination rates among women who have recently given birth in the United States, as well as shifts in healthcare providers' guidance on flu vaccination for pregnant women, we will conduct a secondary analysis of data from the CDC's Pregnancy Risk Assessment Monitoring System (PRAMS). This analysis will use relevant survey items from PRAMS Phases 5 (2004-2008), 6 (2009-2011), 7 (2012-2015), and 8 (2016-2022) related to influenza vaccine knowledge, opinions, behaviors, and health care provider recommendations before and during pregnancy. Descriptive analyses will be conducted using SPSS Version 29 with Complex Samples Add-On to evaluate changes in responses across the four PRAMS phases. The results of this study will provide further context around current suboptimal rates of influenza vaccination among pregnant women by investigating trends in PRAMS respondents’ receipt of the vaccine and perceptions of health care providers’ vaccine recommendations over an 18-year period. These findings can be used to guide the development of tailored education interventions for pregnant women and their health care providers to increase rates of influenza vaccination during pregnancy.
Start Time
16-4-2025 9:00 AM
End Time
16-4-2025 11:30 AM
Presentation Type
Poster
Presentation Category
Health
Student Type
Clinical Doctoral Student (e.g., medical student, pharmacy student)
Faculty Mentor
KariLynn Dowling-McClay
Faculty Department
Pharmacy Practice
Trends in Influenza Vaccination Among Pregnant Women: A Secondary Analysis of PRAMS
The CDC Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists recommend that all pregnant women receive the annual influenza vaccine to protect themselves and their infants. Because flu vaccines cannot be given to infants less than six months of age, vaccinating pregnant mothers allows influenza antibodies to pass on to the infant and protect them for the first months of life. Despite these longstanding public health recommendations, recent data collected by the CDC found that influenza vaccination rates among pregnant women were under 50% in the 2023-2024 flu season. To examine broader trends over time in influenza vaccination rates among women who have recently given birth in the United States, as well as shifts in healthcare providers' guidance on flu vaccination for pregnant women, we will conduct a secondary analysis of data from the CDC's Pregnancy Risk Assessment Monitoring System (PRAMS). This analysis will use relevant survey items from PRAMS Phases 5 (2004-2008), 6 (2009-2011), 7 (2012-2015), and 8 (2016-2022) related to influenza vaccine knowledge, opinions, behaviors, and health care provider recommendations before and during pregnancy. Descriptive analyses will be conducted using SPSS Version 29 with Complex Samples Add-On to evaluate changes in responses across the four PRAMS phases. The results of this study will provide further context around current suboptimal rates of influenza vaccination among pregnant women by investigating trends in PRAMS respondents’ receipt of the vaccine and perceptions of health care providers’ vaccine recommendations over an 18-year period. These findings can be used to guide the development of tailored education interventions for pregnant women and their health care providers to increase rates of influenza vaccination during pregnancy.